Michael X.Y. Zhang

Michael Zhang is an associate in the Corporate Practice Group, Antitrust Practice Group and the Intellectual Property Practice Group in the firm's Shanghai office.  He has a deep understanding of China’s legal system and business practices.

Areas of Practice

Mr. Zhang has broad experience in the areas of corporate law, antitrust law and intellectual property law in China.

He has represented many U.S., European and Chinese clients in a wide range of industries with respect to their mergers and acquisitions and joint venture projects in China, including automobile, diesel engine, material hi-tech, telecommunication and software sectors. 

Mr. Zhang is experienced with IP licensing, IP due diligence and corporate IP protection within M&A transactions and joint venture projects.  He also has expertise with the protection of his client’s IP rights against counterfeiting and piracy in China. 

With rich knowledge of China’s and other East Asian countries’ antitrust laws, Mr. Zhang counsels U.S. and international clients on antitrust issues.  He has extensively reviewed, written articles on, and advised clients regarding the proposed draft of China’s first Anti-Monopoly Law.

Education

• LL.B., Law School of Shanghai Institute of Foreign Trade

Admissions

• National Bar Exam
• Non-practicing People’s Republic of China attorney

Languages

• Mandarin Chinese

Representative Matters

Represented one of the largest Chinese venture capital investor in a joint venture project with a worldwide leading software company.

Represented a leading Fortune 500 company in the materials industry on its business expansion in China, including advising on franchising strategy and on IP protection.

Represented a world leading car carrier company in establishing five joint ventures in Shanghai, Dalian, Shenyang and Tianjin.

Represented a leading Fortune 500 company on its M&A business in China and conducted IP due diligence on one of the largest Chinese engine manufacturers.

Advised world leading enterprise resource planning company regarding its IP protection in China and designed the company’s internal IP protection policy.

Represented one of the leading U.S. medical companies in handling its contractual disputes with a Chinese manufacturer.

Articles

• Suggestions On Regulatory Compliance With The New Anti-monopoly Law For Multinational Companies In China, China Law & Practice, October 1, 2007
• Impact of New Anti-Monopoly Law of PRC on International Mergers and Aquisitions, China Legal Review, September 1, 2007